ADB allocates $20 million to help developing members access vaccines for COVID-19

ADB allocates $20 million to help developing members access vaccines for COVID-19 The funds will be available for ADB developing members to support vaccine-related health system assessments and the development of country readiness plans to strengthen the capacity to access, introduce, deploy, deliver, and monitor vaccines safely and effectively.

No comments:

Post a Comment